Sentinel Oncology Limited
- Company number
- 05336536
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 19 Jan 2005
- Nature of business
- Research and experimental development on biotechnology
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| COWELL, Daniel | Director | 14 Mar 2011 | |
| DIXON, John, Dr | Director | 1 Feb 2010 | |
| VENKITARAMAN, Ashok, Professor | Director | 27 Mar 2006 | |
| BOYLE, Robert George | Director | 30 Jun 2005 | |
| SIMPSON, Gavin Alexander | Director | 17 May 2005 | |
| TRAVERS, Stuart | Director | 19 Jan 2005 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Mr Stuart Travers | Significant Influence Or Control | 29 Jan 2025 | |
| Mr Robert George Boyle | Significant Influence Or Control | 29 Jan 2025 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Mar 2025 | £4,721,277 | £4,684,447 | 5 |
| 31 Mar 2024 | £5,409,885 | £5,560,297 | 6 |
| 31 Mar 2023 | £2,935,753 | £3,598,219 | 5 |
| 31 Mar 2022 | £3,204,881 | £3,546,144 | 5 |
| 31 Mar 2021 | £2,680,965 | £2,706,673 | 5 |
| 31 Mar 2020 | £872,135 | £628,658 | 5 |
| 31 Mar 2019 | £722,409 | £482,773 | 4 |
| 31 Mar 2018 | £796,945 | £527,392 | 4 |
| 31 Mar 2017 | £865,085 | £719,695 | 4 |
| 31 Mar 2016 | £563,130 | £469,220 | - |
| 31 Mar 2015 | £687,403 | £612,651 | - |
| 31 Mar 2014 | - | - | - |
| 31 Mar 2013 | £64,696 | £54,237 | - |
| 31 Mar 2012 | -£1,188,980 | £194,077 | - |
| 31 Mar 2011 | -£1,462,583 | £138,179 | - |
| 31 Mar 2010 | - | - | - |
| 31 Mar 2009 | - | - | - |
| 31 Mar 2008 | - | - | - |
| 31 Mar 2007 | - | - | - |
| 31 Mar 2006 | - | - | - |
Connections
Controls
- Apherion Therapeutics Limited (16879736)
Directors’ other companies
- DIXON, John, Dr - Director at J D International Consulting Limited